At a glance
ClinicalIndex Comparison RecordN/ACompleted· 295 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
National, Cross-sectional, Multicenter Study to Estimate the Point Prevalence of Peripheral Intravenous Catheter-related Complications in Brazil: a Quality Improvement Study (PIVS)
In Brief
An observational study for Infusion Site Injury. Completed, enrolled 295 participants across 3 sites.
Detailed Summary
A multi-center, national prevalence study where: (1) baseline SPIVC therapy complications of hospitalized adult patients that meet the inclusion/exclusion criteria of the study and (2) the compliance of clinicians to the Hospital's evidence based practice will be measured in Brazil.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInfusion Site Injury
CountriesBrazil
CollaboratorsEurotrials Brasil Consultores Cientificos Ltda, 3M
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartJan 2019
Primary CompletionJul 2019
Study CompletionOct 2019
TodayJul 2026
First PostedOct 25, 2018
Enrollment StartJan 7, 2019
Primary CompletionJul 31, 2019
Study CompletionOct 1, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.7 years ago